Top Markets
#1 Velas Velas +367.73%
#2 Gravity Gravity +49.04%
#3 Galxe Galxe +34.81%
#4 Derive Derive +31.02%
#5 Infinity Ground Infinity Ground +29.01%
#6 Audiera Audiera +25.57%
#7 Wiki Cat Wiki Cat +25.37%
#8 Wrapped QUIL Wrapped QUIL +22.19%
#9 Aria.AI Aria.AI +21.09%
#10 Fetch.ai Fetch.ai +20.92%
Coin of the day
Velas Velas
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
MultiCell Technologies, Inc. MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET
Rankning i aktier #20716
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel... MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.
Aktiekurs
$0.00001
Marknadsvärde
$50.01K
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel MultiCell Technologies, Inc. (MCET)

Kategori

Healthcare
Marknadsvärde
Intäkter
mer
Vinst
Prisets historik
P/E-tal
P/S-tal
P/B-tal
Rörelsemarginal
VPA
Aktiesplit
Utdelningar
Direktavkastning
Utestående aktier
P/S-tal för MultiCell Technologies, Inc. (MCET)
P/S-tal per March 2026 TTM: 1.01K
Enligt MultiCell Technologies, Inc. senaste finansiella rapporter och aktiekurs är det aktuella P/S-talet (TTM) 1.01K. I slutet av 2013 hade företaget ett P/S-tal på 27.21.
Historik för P/S-tal för MultiCell Technologies, Inc. från 2013 till 2026
P/S-tal vid årets slut
År P/S-tal Ändra
2026 (TTM) 1.01K 3,255.43%
2014 30.22 11.07%
2013 27.21 0.00%
P/S-tal för liknande företag eller konkurrenter
Företag P/S-tal Skillnad i P/S-tal Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
3.55 -99.65%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.90 -99.02%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
5.40 -99.47%
US
UCB SA UCB SA
UCB SA
UCB.BR
6.14 -99.39%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.04 -99.70%
AU